Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patients after allogeneic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection
• Human Herpesvirus-6 Infection
• Jc Virus Infection

Drugs mentioned

• Posoleucel (Posoleucel)

Snippet

Sponsor: AlloVir | Conditions: Adenovirus Infection, BK Virus Infection | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-05-16